Busceti C, Di Menna L, Castaldi S, DErrico G, Taddeucci A, Bruno V
eNeuro. 2024; 11(8).
PMID: 38969501
PMC: 11298959.
DOI: 10.1523/ENEURO.0523-23.2024.
Armenta-Resendiz M, Carter J, Hunter Z, Taniguchi M, Reichel C, Lavin A
Psychopharmacology (Berl). 2024; 241(11):2331-2345.
PMID: 38953940
PMC: 11513735.
DOI: 10.1007/s00213-024-06638-1.
Daiwile A, Cadet J
Adv Pharmacol. 2024; 99:145-168.
PMID: 38467480
PMC: 11474929.
DOI: 10.1016/bs.apha.2023.08.002.
Tian W, Zhao D, Ding J, Zhan S, Zhang Y, Etkin A
Cell Rep Med. 2023; 5(1):101347.
PMID: 38151021
PMC: 10829728.
DOI: 10.1016/j.xcrm.2023.101347.
Kong D, Sun J, Yang J, Li Y, Bi K, Zhang Z
Front Nutr. 2023; 10:1191903.
PMID: 37575322
PMC: 10414993.
DOI: 10.3389/fnut.2023.1191903.
Sex- and Gender-Specific Drug Abuse Dynamics: The Need for Tailored Therapeutic Approaches.
Marinelli S, Basile G, Manfredini R, Zaami S
J Pers Med. 2023; 13(6).
PMID: 37373954
PMC: 10304701.
DOI: 10.3390/jpm13060965.
Aberrant topology of white matter networks in patients with methamphetamine dependence and its application in support vector machine-based classification.
Cheng P, Li Y, Wang G, Dong H, Liu H, Shen W
Sci Rep. 2023; 13(1):6958.
PMID: 37117256
PMC: 10147725.
DOI: 10.1038/s41598-023-33199-8.
Dynamics of intrinsic whole-brain functional connectivity in abstinent males with methamphetamine use disorder.
Jiang P, Sun J, Zhou X, Lu L, Li L, Xu J
Drug Alcohol Depend Rep. 2023; 3:100065.
PMID: 36845989
PMC: 9949309.
DOI: 10.1016/j.dadr.2022.100065.
Associations of executive function and age of first use of methamphetamine with methamphetamine relapse.
Mu L, Wang Y, Wang L, Xia L, Zhao W, Song P
Front Psychiatry. 2022; 13:971825.
PMID: 36311529
PMC: 9608758.
DOI: 10.3389/fpsyt.2022.971825.
Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex.
Armenta-Resendiz M, Assali A, Tsvetkov E, Cowan C, Lavin A
Neuropsychopharmacology. 2022; 47(10):1816-1825.
PMID: 35788684
PMC: 9372065.
DOI: 10.1038/s41386-022-01371-9.
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts.
Daiwile A, Jayanthi S, Cadet J
Neurosci Biobehav Rev. 2022; 137:104674.
PMID: 35452744
PMC: 9119944.
DOI: 10.1016/j.neubiorev.2022.104674.
Effects of cytidine-5'-diphosphate choline on gray matter volumes in methamphetamine-dependent patients: A randomized, double-blind, placebo-controlled study.
Jeong H, Yoon S, Sung Y, Kim J, Lyoo I, Yurgelun-Todd D
J Psychiatr Res. 2021; 143:215-221.
PMID: 34507102
PMC: 8557135.
DOI: 10.1016/j.jpsychires.2021.09.006.
Reduced fractional anisotropy in projection, association, and commissural fiber networks in neonates with prenatal methamphetamine exposure.
Warton F, Taylor P, Warton C, Molteno C, Wintermark P, Zollei L
Dev Neurobiol. 2020; 80(11-12):381-398.
PMID: 33010114
PMC: 7855045.
DOI: 10.1002/dneu.22784.
Methamphetamine Users Show No Behavioral Deficits in Response Selection After Protracted Abstinence.
Bensmann W, Ernst J, Radle M, Opitz A, Beste C, Stock A
Front Psychiatry. 2019; 10:823.
PMID: 31803080
PMC: 6877501.
DOI: 10.3389/fpsyt.2019.00823.
A new challenge for expert witnesses relying on subjective information.
Fisher Retired B
Forensic Sci Res. 2018; 2(3):113-114.
PMID: 30483628
PMC: 6197117.
DOI: 10.1080/20961790.2017.1342587.
Violent offences of methamphetamine users and dilemmas of forensic psychiatric assessment.
Liu Y, Hao B, Shi Y, Xue L, Wang X, Chen Y
Forensic Sci Res. 2018; 2(1):11-17.
PMID: 30483614
PMC: 6197090.
DOI: 10.1080/20961790.2017.1287155.
Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study.
Vuletic D, Dupont P, Robertson F, Warwick J, Zeevaart J, Stein D
Neuroimage Clin. 2018; 20:1157-1162.
PMID: 30380522
PMC: 6205927.
DOI: 10.1016/j.nicl.2018.10.023.
Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving.
Cates H, Li X, Purushothaman I, Kennedy P, Shen L, Shaham Y
Neuropsychopharmacology. 2018; 43(12):2426-2434.
PMID: 30072726
PMC: 6180053.
DOI: 10.1038/s41386-018-0158-x.
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment.
Moszczynska A, Callan S
J Pharmacol Exp Ther. 2017; 362(3):474-488.
PMID: 28630283
PMC: 11047030.
DOI: 10.1124/jpet.116.238501.
Enduring Loss of Serotonergic Control of Orbitofrontal Cortex Function Following Contingent and Noncontingent Cocaine Exposure.
Wright A, Zapata A, Baumann M, Elmore J, Hoffman A, Lupica C
Cereb Cortex. 2016; 27(12):5463-5476.
PMID: 27733540
PMC: 6075564.
DOI: 10.1093/cercor/bhw312.